Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.115948 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Ge Song und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Re…. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, COVID-19, Antibodies, Viral. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases Division of Intramural Research, Argonne National Laboratory, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vac…
- Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
- Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
- Department of Computer Science, Johns Hopkins University, Baltimore, MD 21218, USA.
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.
Förderung
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
- Argonne National Laboratory
- National Institute of Allergy and Infectious Diseases
- Bill and Melinda Gates Foundation
- Basic Energy Sciences
- National Institute of General Medical Sciences
- SLAC National Accelerator Laboratory
- U.S. Department of Energy
Zitieren
APA
Song, G., Yuan, M., Liu, H., Capozzola, T., Lin, R. N., Torres, J. L., He, W. T., Musharrafieh, R., Dueker, K., Zhou, P., Callaghan, S., Mishra, N., Yong, P., Anzanello, F., Avillion, G., Vo, A. L., Li, X., Zhang, Y., Makhdoomi, M., …, & Andrabi, R. (2025). Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115948
Vancouver
Song G, Yuan M, Liu H, Capozzola T, Lin RN, Torres JL, et al. Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115948
BibTeX
@article{Song2025,
author = {Song, Ge and Yuan, Meng and Liu, Hejun and Capozzola, Tazio and Lin, Ryan N and Torres, Jonathan L and He, Wan-Ting and Musharrafieh, Rami and Dueker, Katharina and Zhou, Panpan and Callaghan, Sean and Mishra, Nitesh and Yong, Peter and Anzanello, Fabio and Avillion, Gabriel and Vo, Anh Lina and Li, Xuduo and Zhang, Yuexiu and Makhdoomi, Muzamil and Feng, Ziqi and Zhu, Xueyong and Peng, Linghang and Nemazee, David and Safonova, Yana and Briney, Bryan and Ward, Andrew B and Burton, Dennis R and Wilson, Ian A and Andrabi, Raiees},
title = {Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.115948}
}
EUVIMED